Transcutaneous electrical nerve stimulation (TENS): A potential intervention for pain management in India?

Banerjee, Gourav; Johnson, Mark I.

doi:10.4103/0970-5333.124590

Cited by 14 publications

(11 citation statements)

References 57 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25,800. [19] Indian physiotherapists use TENS predominantly for musculoskeletal pain and neuropathic pain and rarely for dysmenorrhea, labor pain, and postoperative pain. TENS devises may be loaned to the patients for their duration of stay during hospital.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

2017

View full text Add to dashboard Cite

Background:Chronic pelvic pain is prevalent in 2% of women population globally. The etiology is multifactorial. Even in the absence of pelvic pathology, there is a subgroup of women who do not respond to analgesic and anti-inflammatory therapy. Chronic pelvic pain can be inhibited by direct inhibition of impulses in the preganglionic afferent neuron by closing the hypothetical gate in the dorsal horn of the spinal cord. Transcutaneous electrical nerve stimulation (TENS) is based on the gate control theory of abolishing the painful stimuli by providing simultaneous inputs in larger myelinated nerve fibers.Aims and Objectives:This study was designed to assess the effectiveness and safety of TENS in idiopathic chronic pelvic pain.Methods:It is a prospective, experimental study to evaluate the effectiveness of TENS versus placebo in reducing pain severity in chronic pelvic pain (G1 = 30, G2 = 32, G3 = 30, and G0 = 30). Patients with chronic pelvic pain due to benign lesions of genital tract, gastrointestinal, and renal disorders were excluded from the study after performing an ultrasound study of abdomen and pelvis. Ten treatment sessions (5 sessions/week) of 30 min were conducted.Observations and Results:There was a significant improvement in pain scores in TENS group as compared with control group, and two patients were completely pain free following TENS therapy.Conclusion:In women patients with idiopathic chronic pelvic pain, TENS can be a useful intervention. TENS units are safe, economical, and easily commercially available.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Carbon electrodes will be a better choice in rural India as self-adhering electrodes deteriorate rapidly if not kept in cool and dust-free area. [19]…”

Section: Discussionmentioning

confidence: 99%

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

2017

View full text Add to dashboard Cite

show abstract

“…), cardiac failure, or arrhythmias; TENS can also lead to misinterpretation of ECG findings. [13][14][15][16] Some studies have investigated TENS effects in patients with cardiac implanted devices; however, these results were mostly retrospective and obtained from case studies. 16,17 To our knowledge, the present study is the first prospective investigation to examine the early and late effects of TENS on ECGs.…”

Section: Discussionmentioning

confidence: 99%

Effect of the Conventional Transcutaneous Electrical Nerve Stimulation on Heart Rhythm

Ağırman¹,

Aydin²

2018

J PMR Sci

View full text Add to dashboard Cite

show abstract

“…There are many non-pharmacological methods for pain relief, including relaxation, distraction, thermotherapy, cryotherapy, and transcutaneous electrical nerve stimulation (TENS) (15). With regard to its great range of frequencies and intensities, TENS has been increasingly administered to relieve pain (16,17). There are numerous studies on pain relief through TENS, which have reached different results.…”

Section: Introductionmentioning

confidence: 99%

An Investigation into the Effect of Transcutaneous Electrical Nerve Stimulation on Postoperative Pain Intensity in Patients with Bone Fracture: A Clinical Trial

et al. 2020

View full text Add to dashboard Cite

Background: From patients' perspective, pain is the most frequent complaint after surgery, which results in many complications such as sleep disorder, atelectasis, myocardial ischemia, respiratory infection, immune system disorder, and anxiety. In this context, deploying complementary and low-risk methods is extremely important in alleviating pain after orthopedic surgery. Objectives: This study explored the impact of transcutaneous electrical nerve stimulation (TENS) on pain intensity in patients after orthopedic surgery. Methods: This clinical trial was performed on 80 individuals admitted to the orthopedic ward of Khatam al-Anbia Hospital, Zahedan, Iran, in 2017. The patients were enrolled at least 24 hours after surgery and randomized into intervention (n = 40) and control (n = 40) groups. Pain was initially measured in the two groups using a visual analog scale. Then, the intervention group received TENS for 30 minutes. Finally, pain scores were re-evaluated in the both groups. Results: The subjects did not have any significant difference in terms of demographic variables. The mean pain intensity after the experiment was significantly different between the intervention (3.17 ± 1.75) and control (4.97 ± 1.86) groups, with the former perceiving less pain. Conclusions: TENS is effective in reducing pain after orthopedic surgery and is suggested to be administered in combination with medication to enhance pain relief.

show abstract

Transcutaneous electrical nerve stimulation (TENS): A potential intervention for pain management in India?

Cited by 14 publications

References 57 publications

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

Efficacy of transcutaneous electrical nerve stimulation in the treatment of chronic pelvic pain

Effect of the Conventional Transcutaneous Electrical Nerve Stimulation on Heart Rhythm

An Investigation into the Effect of Transcutaneous Electrical Nerve Stimulation on Postoperative Pain Intensity in Patients with Bone Fracture: A Clinical Trial

Contact Info

Product

Resources

About